PKM2 is known to promote cell migration and inhibits autophagy by mediating PI3K/AKT activation in gastric cancer or metastasis by recruiting myeloid-derived suppressor cells; and PKM2 expression is a marker of poor prognosis in hepatocellular carcinoma (39, 40). Here, PKM is linked to gastric cancer.